{"id":22408,"date":"2012-04-20T14:48:38","date_gmt":"2012-04-20T18:48:38","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=22408"},"modified":"2012-04-21T19:38:58","modified_gmt":"2012-04-21T23:38:58","slug":"a-random-word-generator","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2012\/04\/20\/a-random-word-generator\/","title":{"rendered":"a random word generator&#8230;"},"content":{"rendered":"\n<div align=\"justify\">Back in the 1980s when I was trying to adapt to the arrival of the new DSM-III psychiatry, I was told that the new brain scanners were going to revolutionize psychiatry by finding the physiologic basis for mental diseases. I didn&#8217;t know how that was going to happen, but we&#8217;re still hearing the same thing nearly thirty years later.<\/div>\n<blockquote>\n<div align=\"center\"><a href=\"http:\/\/www.dsm5.org\/Research\/Documents\/Kupfer%20Regier_RDoC%20Commentary_AJP%20July%202011.pdf\" target=\"_blank\"><font color=\"#200020\"><u><strong>Neuroscience, Clinical Evidence, and the Future of Psychiatric Classification in DSM-5<\/strong><\/u><\/font><\/a><br \/>                          <sup>by David J. Kupfer, M.D. and  Darrel A. Regier, M.D., M.P.H.<\/sup><br \/>                          <font color=\"#004400\"><strong>American Journal of Psychiatry<\/strong><\/font> 168:672-674, 2011.<\/div>\n<p>         <\/p>\n<div align=\"justify\"><sup>In  the initial stages of development of the  fifth edition of the  Diagnostic and Statistical Manual of Mental  Disorders,we expected that  some of the limitations of the current  psychiatric diagnostic criteria  and taxonomy would be mitigated by the  integration of validators  derived from scientific advances in the last  few decades. <strong><font color=\"#990000\">Throughout  the last 25 years of psychiatric research,  findings from genetics,  neuroimaging, cognitive science, and  pathophysiology have yielded  important insights into diagnosis and  treatment approaches for some  debilitating mental disorders, including  depression, schizophrenia, and  bipolar disorder.<\/font><\/strong><\/sup><sup> In <strong><em><u>A Research Agenda for DSM-V<\/u><\/em><\/strong>,   we anticipated that these emerging diagnostic and treatment advances   would impact the diagnosis and classification of mental disorders faster   than what has actually occurred&hellip;<\/sup><\/div>\n<\/blockquote>\n<blockquote>\n<div align=\"center\"><a target=\"_blank\" href=\"http:\/\/www.medscape.com\/viewarticle\/750288\"><u><strong><font color=\"#200020\">Psychiatric Diagnosis in the Lab: How Far Off Are We?<\/font><\/strong><\/u><\/a><br \/>                             <strong><font color=\"#200020\">Medscape News<\/font><\/strong><br \/>                             by Jeffrey A. Lieberman, MD<br \/>                             09\/28\/2011<\/div>\n<p>                <\/p>\n<div align=\"justify\"><sup>&hellip;we  anticipated that this iteration of the  DSM would incorporate   biological markers and laboratory-based test  results to augment the   historical and phenomenologic criteria that  traditionally are used to   establish psychiatric diagnoses. Sadly, this  has proved to be beyond  the  reach of the current level of evidence&hellip; In recent years, however,  we have  seen the emergence and refinement of a  number of different  technologies  that I predict will, within our  professional lifetimes  and hopefully  within the next 5 years, lead to  the incorporation of  laboratory-based  tests for psychiatric diagnosis&#8230;<\/p>\n<p>         &#8230;likely to be implemented for psychiatric diagnosis is that of <strong><font color=\"#990000\">imaging techniques; here we&#8217;re talking about both nuclear medicine imaging with PET and MR imaging with either structural, spectroscopic, or functional imaging applications. These have been used in a variety of disorders. They yield clear differences between, diagnostic groups such as schizophrenia or depression on one hand and healthy volunteer controls or nonaffected individuals on the other.<\/font><\/strong> The problem is that the distributions of the values of the control vs patient groups still have too much overlap and are not sufficiently differentiated as to provide high enough positive predictive value at the individual patient or subject level. But I predict that it won&#8217;t be too long before these are refined, the results will become more robust, and these will contribute to a profile or augment the information that clinicians have to establish their diagnosis&#8230;<\/sup><\/div>\n<\/blockquote>\n<blockquote>\n<div align=\"center\"><a target=\"_blank\" href=\"http:\/\/www.bmj.com\/content\/343\/bmj.d5581.extract?ct\"><u><strong><font color=\"#200020\">Brain circuitry model for mental illness will transform management, NIH mental health director says<\/font><\/strong><\/u><\/a><br \/>         <strong><font color=\"#0066ff\">British Medical Journal<\/font><\/strong><br \/>         by Caroline White<br \/>         1 September 2011<\/div>\n<p>   <\/p>\n<div align=\"justify\"><sup>The field of mental health is on the cusp of a  revolution, which is set to transform the diagnosis and treatment of  mental illness and reverse the lack of major progress made in curbing  associated ill health and death over the past 100 years, the director of  the US National Institute of Mental Health, has claimed. &ldquo;We are at an  extraordinary moment when the entire scientific foundation for mental  health is shifting, with the 20th century discipline of psychiatry  becoming the 21st century discipline of clinical neuroscience,&rdquo; Thomas  Insel said before a meeting on the challenges facing mental health  research at the Royal Society in London on 31 August&hellip;<\/p>\n<p>  The seismic shift had been driven by what he  described as three &ldquo;revolutionary changes&rdquo; in thinking, the first of  which was that <strong><font color=\"#990000\">mental illness was increasingly being recognised as a  disorder of brain circuitry, rather than as a chemical imbalance, thanks  to neuroimaging techniques and the discovery of some key biomarkers<\/font><\/strong>.  Secondly, mental ill health was now recognised as a developmental  disorder for which early intervention was vital, said Professor Insel,  highlighting US research showing that 50% of study participants had  reported the onset of mental health problems by the age of 14, and 75%  by the age of 24. &ldquo;We are still stuck with getting to the problem very  late. The future will be about understanding the trajectory of illness  so that we can identify the first signs before it develops into  psychosis,&rdquo; he said&hellip;<\/sup><\/div>\n<\/blockquote>\n<div>When I read things like &quot;recent advances in genomics, neuroimaging, proteonomics&#8230;&quot; [which is often], I never really know what advances they&#8217;re talking about. I&#8217;ve recently been trying to understand an article from a neuroimaging study [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22267183\" target=\"_blank\"><u><strong><font color=\"#200020\">Brain Activity in Adolescent Major Depressive Disorder Before and After Fluoxetine Treatment<\/font><\/strong><\/u><\/a>, see <u><strong><a href=\"http:\/\/1boringoldman.com\/index.php\/2012\/04\/08\/wary-skepticism\/\" target=\"_blank\"><font color=\"#200020\">wary skepticism&hellip;<\/font><\/a><\/strong><\/u>], and I must say that my progress is slow. Here&#8217;s what [I think] I&#8217;ve learned so far. It&#8217;s a Functional MRI [fMRI] &#8211; BOLD [blood-oxygen-level-dependent]. It relies on the fact that oxygenated hemoglobin is weakly repelled by magnets and deoxygenated hemoglobin is attracted by magnets. So the fMRI is measuring the oxygen rich blood flow that occurs when neurons fire, essentially &quot;lighting up&quot; an area where there&#8217;s a lot of activity. It lasts for only a few seconds. In practice, the subject is given a task\/stimulus, and they measure what &quot;lights up&quot; during the task. But then comes something that sounds like this&#8230;<\/div>\n<ul>\n<div align=\"justify\"><sup>The SPM5 software package [London, Wellcome Department of Imaging Neuroscience] was used to analyze the functional imaging data. Data were slice-time corrected for an interleaved bottom-up acquisition, adjusted for motion, and spatially normalized into a standard Montreal Neurological Institute [MNI] template. The image volume was then spatially smoothed with a 6-mm full width at half maximum Gaussian filter. Signal changes were modeled using the stimulation paradigm convolved with a canonical hemodynamic response function. Initial single-subject level analyses using a within-subject fixed-effects model were conducted to generate parametric maps for the three block conditions: neutral, fearful, and fixation. Results from the withinsubject analyses were then used for subsequent second-level random-effects models. Whole brain level t tests [two-sample and paired-sample] for the fearful &gt; neutral contrast were conducted initially to guide subsequent region-of-interest analyses. Then a priori region-of-interest analyses were performed in regions of the amygdala, orbitofrontal cortex, and subgenual anterior cingulate cortex. Anatomic masks for the regions of interest were created using the automated anatomical labeling atlas in the Wake Forest University PickAtlas utility. Activations within the regions of interest had to survive a small-volume correction at a threshold of p&lt;0.05. Single-subject percent signal changes were then calculated using the MarsBaR toolbox in SPM5. Functional masks for the amygdala were created using the voxels [five or more contiguous voxels] that showed a significant group-by-time interaction from the repeated-measures analysis of variance [ANOVA]. Masks for the orbitofrontal cortex and the subgenual anterior cingulate cortex were created using voxels from the baseline two-sample t tests. The percent signal change calculation allowed us not only to verify the results from the SPM5 analyses but also to account for other covariates in the analyses [baseline activation, gender, age, depression severity, and so on] using SAS, version 9.2 [SAS Institute, Inc., Cary, N.C.]. Thus, separate 2&times;2 [group-by-time] repeated-measures ANOVAs in SPM5 and a mixed linear model analysis of repeated measures with the Kenward-Roger correction applied to the unstructured covariance model in SAS were conducted to examine the differences in amygdala, orbitofrontal cortex, and subgenual anterior cingulate cortex activations between depressed adolescents and healthy comparison subjects for the fearful &gt; neutral contrast over 8 weeks. Post hoc t tests in SPM5 and one-way ANOVAs or oneway analyses of covariance in SAS were conducted to evaluate the significant group-by-time interaction simple effects at baseline and at week 8, respectively. Additionally, mean changes in activation and the effect size of the change [Cohen&rsquo;s d] from baseline to week 8 for each region were examined using mean contrasts. <\/sup><\/div>\n<\/ul>\n<div align=\"justify\">&#8230;and I know that I&#8217;ve been had. How can a routine reader [even a non-routine reader] evaluate the worth of what follows after that? I would suggest that the recent advance in neuroimaging we need is some kind of standard or cross validation to assure us that the methods section wasn&#8217;t written by a random word generator using a scientific glossary. <\/div>\n","protected":false},"excerpt":{"rendered":"<p>Back in the 1980s when I was trying to adapt to the arrival of the new DSM-III psychiatry, I was told that the new brain scanners were going to revolutionize psychiatry by finding the physiologic basis for mental diseases. I didn&#8217;t know how that was going to happen, but we&#8217;re still hearing the same thing [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-22408","post","type-post","status-publish","format-standard","hentry","category-politics"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/22408","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=22408"}],"version-history":[{"count":13,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/22408\/revisions"}],"predecessor-version":[{"id":22505,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/22408\/revisions\/22505"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=22408"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=22408"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=22408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}